Market Research

Global Medical Foods for Inborn Errors of Metabolism Market

Best Price Guarantee Length Publisher Published Date SKU
from $4,800 688 Pages Data Bridge Market Research April, 2024 DAABD18813148
Best Price Guarantee
Price from $4,800
Length 688 Pages
Publisher Data Bridge Market Research
Published Date April, 2024
SKU DAABD18813148

Global Medical Foods for Inborn Errors of Metabolism Market


Global medical foods for inborn errors of metabolism market is expected to reach USD 7,998.77 million by 2031 from USD 2,477.81 million in 2022, growing at a CAGR of 14.1% during the forecast period of 2023 to 2031.
Market Segmentation
Global Medical Foods For Inborn Errors Of Metabolism Market, By Products (Amino Acid, Low Protein Food, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, and Others), Diseases (Phenylketonuria (PKU), Ryrosinemia Types I And II, Maple Syrup Urine Disease (MSUD), Homocystinuria, Glutaric Acidemia Type I, Urea Cycle Disorders, Methylmalonic Acidemia, Isovaleric Acidemia, Organic Acidurias, Renal Disease, Propionic Academia, Disorders Of Leucine Metabolism, and Others), Age Group (Infants, Weaning, Adolescent, and Adults), Forms (Powder, Liquid, Tablets , Gels, and Others), Packaging (Can, Jar, Packets, Bottle, and Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Drugs Store, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, Belgium, Denmark, Russia, Sweden, Turkey, Poland, Finland, Norway, Rest of Europe, China, Japan, India, Australia, South Korea, Thailand, Singapore, Indonesia, Malaysia, New Zealand, Vietnam, Philippines, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, Bahrain, United Arab Emirates, Kuwait, Qatar, Egypt, Oman, and Rest of Middle East and Africa) – Industry Trends and Forecast to 2031

Overview of Global Medical Foods for Inborn Errors of Metabolism Market Dynamics:

Drivers
• Rising incidence of inborn errors of metabolism
• Rising preference of dietary supplements over enzyme replacement therapy
• Increase in the number of new born screening procedures
• Increasing spending on medical food products
Restraints
• High cost of medical food
• Stringent regulations for medical foods
Opportunities
• Government initiatives and programs for creating awareness about IEM
• Increasing collaboration and partnerships in the market
• Expansion of medical foods in emerging market
Challenges
• Poor accessibility of medical foods
• Alternative treatment approaches for inborn errors of metabolism



Market Players:

The key market players operating in the global medical foods for inborn errors of metabolism market are listed below:
• Abbott
• Nestlé Health Science
• Meiji Holdings Co., Ltd
• Baxter
• Pristine Organics Pvt Ltd.
• Promin
• Solace Nutrition
• EBM Medical, Galen Limited
• Hexagon Nutrition Ltd.
• Kate Farms
• Ajinomoto Cambrooke, Inc.
• Mead Johnson & Company, LLC.
• Nutricia
• B. Braun SE
• Orpharma Pty Ltd.
• Piam Farmaceutici S.P.A.
• PKU-Mdmil.com
• Primus Pharmaceuticals, inc.
• Biovencer Healthcare Pvt Ltd

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 DBMR Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 DBMR Market Position Grid
2.8 Secondary Sources
2.9 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Epidemiology
4.1.1 Prevalence Of Inborn Errors Of Metabolism
4.1.2 New-born Screening Programs
4.1.3 Genetic Heterogeneity
4.1.4 Impact On Health
4.1.5 Clinical Impac
4.1.6 Treatment And Management
4.2 Pestle Analysis
4.2.1 Political Factors
4.2.2 Economic Factors
4.2.3 Social Factors
4.2.4 Technological Factors
4.2.5 Environmental Factors
4.2.6 Legal Factors
4.3 Porter’s Five Forces
4.3.1 Threat Of New Entrants
4.3.2 Threat Of Substitutes
4.3.3 Bargaining Power Of Buyers
4.3.4 Bargaining Power Of Suppliers
4.3.5 Competitive Rivalry
4.4 Industry Insights
4.4.1 Demographic Trends
4.4.2 Key Pricing Strategies
4.4.3 Key Patient Enrollment Strategies
4.5 Patent Analysis
4.6 Pipeline Analysis
4.6.1 Research And Development
4.6.2 Clinical Trials
4.6.3 Regulatory Approval
4.6.4 Manufacturing And Production
4.6.5 Commercialization And Market Access
4.6.6 Distribution And Supply Chain Management
4.6.7 Post-market Surveillance And Monitoring
4.7 Regulation Coverage
5 Market Overview
5.1 Drivers
5.1.1 Rising Incidences Of Inborn Errors Of Metabolism (Iem)
5.1.2 Rising Preference For Dietary Supplements Over Enzyme Replacement Therapy (Ert)
5.1.3 Increase In The Number Of New-born Screening Procedures
5.1.4 Increasing Spending On Medical Food Products
5.2 Restraints
5.2.1 High Cost Of Medical Foods
5.2.2 Stringent Regulations For Medical Foods
5.3 Opportunities
5.3.1 Government Initiatives And Programs For Creating Awareness About Inborn Errors Of Metabolism
5.3.2 Increasing Collaborations And Partnerships In The Market
5.3.3 Expansion Of Medical Foods In Emerging Markets
5.4 Challenges
5.4.1 Poor Accessibility Of Medical Foods
5.4.2 Alternative Treatment Approaches For Inborn Errors Of Metabolism
6 Global Medical Foods For Inborn Errors Of Metabolism Market, By Products
6.1 Overview
6.2 Amino Acid
6.2.1 Amino Acid, By Products
6.2.1.1 Amino Acid Mixtures, By Products
6.2.1.2 Phenylade, By Products
6.2.1.1 Single Amino Acids, By Products
6.3 Low Protein Food
6.3.1 Low Protein Food, By Products
6.4 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron
6.4.1 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron, By Flavors
6.4.2 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron, By Usages
6.5 Low-calcium/Vitamin D-free Infant Formula With Iron
6.5.1 Low-calcium/Vitamin D-free Infant Formula With Iron, By Products
6.6 Others
7 Global Medical Foods For Inborn Errors Of Metabolism Market, By Diseases
7.1 Overview
7.2 Phenylketonuria (Pku)
7.2.1 Phenylketonuria (Pku), By Diseases
7.3 Tyrosinemia Types I And Ii
7.4 Maple Syrup Urine Disease (Msud)
7.4.1 Maple Syrup Urine Disease (Msud), By Diseases
7.5 Homocystinuria
7.5.1 Glutaric Acidemia Type I
7.6 Urea Cycle Disorders
7.6.1 Urea Cycle Disorders, By Diseases
7.7 Methylmalonic Acidemia
7.7.1 Isovaleric Acidemia
7.8 Organic Acidurias
7.9 Renal Disease
7.10 Propionic Acidemia
7.11 Disorders Of Leucine Metabolism
7.12 Others
8 Global Medical Foods For Inborn Errors Of Metabolism Market, By Age Group
8.1 Overview
8.2 Infants
8.3 Weaning
8.4 Adolescent
8.5 Adults
9 Global Medical Foods For Inborn Errors Of Metabolism Market, By Forms
9.1 Overview
9.2 Powder
9.3 Liquid
9.4 Tablets
9.5 Gels
9.6 Others
10 Global Medical Foods For Inborn Errors Of Metabolism Market, By Packaging
10.1 Overview
10.2 Can
10.3 Packets
10.4 Bottle
10.5 Jar
10.6 Others
11 Global Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel
11.1 Overview
11.2 Hospital Pharmacy
11.3 Retail Pharmacy
11.4 Drug Stores
11.5 Online Pharmacy
11.6 Others
12 Global Medical Foods For Inborn Errors Of Metabolism Market, By Region
12.1 Overview
12.2 North America
12.2.1 U S
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 U K
12.3.4 Italy
12.3.5 Spain
12.3.6 Switzerland
12.3.7 Netherland
12.3.8 Belgium
12.3.9 Denmark
12.3.10 Russia
12.3.11 Sweden
12.3.12 Turkey
12.3.13 Poland
12.3.14 Finland
12.3.15 Rest Of Europe
12.4 Asia-pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Australia
12.4.5 South Korea
12.4.6 Thailand
12.4.7 Singapore
12.4.8 Indonesia
12.4.9 Malasia
12.4.10 New Zealand
12.4.11 Vietnam
12.4.12 Philippines
12.4.13 Taiwan
12.4.14 Rest Of Asia-pacific
12.5 South America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Rest Of South America
12.6 Middle East And Africa
12.6.1 South Africa
12.6.2 Saudi Arabia
12.6.3 Bahrain
12.6.4 United Arab Emirates
12.6.5 Kuwait
12.6.6 Qatar
12.6.7 Egypt
12.6.8 Oman
12.6.9 Rest Of Middle East And Africa
13 Global Medical Foods For Inborn Errors Of Metabolism Market: Company Landscape
13.1 Company Share Analysis: Global
13.2 Company Share Analysis: North America
13.3 Company Share Analysis: Europe
13.4 Company Share Analysis: Asia-pacific
14 Swot Analysis
15 Company Profile
15.1 Abbott
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Development
15.2 Nestlé Health Science (A Subsidiary Of Nestlé)
15.2.1 Company Snapshot
15.2.2 Company Share Analysis
15.2.3 Product Portfolio
15.2.4 Recent Developments
15.3 Meiji Holdings Co., Ltd.
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Developments
15.4 Baxter
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Development
15.5 Pristine Organics Pvt Ltd.
15.5.1 Company Snapshot
15.5.2 Company Share Analysis
15.5.3 Product Portfolio
15.5.4 Recent Development
15.6 Ajinomoto Cambrooke, Inc. (A Subsidiary Of Ajinomoto Co., Inc.)
15.6.1 Company Snapshot
15.6.2 Product Portfolio
15.6.3 Recent Developments
15.7 B.Braun Se
15.7.1 Company Snapshot
15.7.2 Product Portfolio
15.7.3 Recent Development
15.8 Biovencer Healthcare Pvt Ltd
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Development
15.9 Ebm Medical
15.9.1 Company Snapshot
15.9.2 Product Portfolio
15.9.3 Recent Development
15.10 Galen Limited
15.10.1 Company Snapshot
15.10.2 Product Portfolio
15.10.3 Recent Developments
15.11 Hexagon Nutrition Ltd.
15.11.1 Company Snapshot
15.11.2 Product Portfolio
15.11.3 Recent Development
15.12 Kate Farms
15.12.1 Company Snapshot
15.12.2 Product Portfolio
15.12.3 Recent Developments
15.13 Mead Johnson & Company, Llc. (A Subsidiary Of Reckitt Benckiser Group Plc.)
15.13.1 Company Snapshot
15.13.2 Product Portfolio
15.13.3 Recent Development
15.14 Nutricia (A Subsidiary Of Danone)
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Orpharma Pty Ltd.
15.15.1 Company Snapshot
15.15.2 Product Portfolio
15.15.3 Recent Development
15.16 Piam Farmaceutici S.P.A
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Pku-mdmil
15.17.1 Company Snapshot
15.17.2 Product Portfolio
15.17.3 Recent Development
15.18 Primus Pharmaceuticals, Inc.
15.18.1 Company Snapshot
15.18.2 Product Portfolio
15.18.3 Recent Development
15.19 Promin
15.19.1 Company Snapshot
15.19.2 Product Portfolio
15.19.3 Recent Development
15.20 Solace Nutrition
15.20.1 Company Snapshot
15.20.2 Product Portfolio
15.20.3 Recent Development
16 Questionnaire
17 Related Reports
Table 1 Costs Of Medical Foods Used In Inborn Errors Of Metabolism (Iems)
Table 2 Patent Analysis
Table 3 Regulatory Coverage
Table 4 Costs Of Medical Foods
Table 5 Global Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 6 Global Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 7 Global Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 8 Global Amino Acids Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 9 Global Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 10 Global Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 11 Global Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 12 Global Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 13 Global Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 14 Global Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 15 Global Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 16 Global Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 17 Global Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 18 Global Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 19 Global Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 20 Global Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 21 Global Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 22 Global Tyrosinemia Types I And Ii In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 23 Global Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 24 Global Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 25 Global Homocystinuria In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 26 Global Glutaric Acidemia Type I In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 27 Global Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 28 Global Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 29 Global Methylmalonic Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 30 Global Isovaleric Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 31 Global Organic Acidurias In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 32 Global Renal Disease In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 33 Global Propionic Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 34 Global Disorders Of Leucine Metabolism In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 35 Global Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 36 Global Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 37 Global Infants In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 38 Global Weaning In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 39 Global Adolescent In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 40 Global Adults In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 41 Global Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 42 Global Powder In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 43 Global Liquid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 44 Global Tablets In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 45 Global Gels In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 46 Global Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 47 Global Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 48 Global Can In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 49 Global Liquid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 50 Global Bottle In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 51 Global Jar In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 52 Global Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 53 Global Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 54 Global Hospital Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 55 Global Retail Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 56 Global Drug Stores In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 57 Global Online Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 58 Global Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 59 Global Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 60 North America Medical Foods For Inborn Errors Of Metabolism Market, By Country, 2018-2031 (Usd Thousand)
Table 61 North America Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 62 North America Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 63 North America Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 64 North America Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 65 North America Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 66 North America Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 67 North America Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 68 North America Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 69 North America Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 70 North America Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 71 North America Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 72 North America Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 73 North America Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 74 North America Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 75 North America Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 76 North America Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 77 North America Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 78 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 79 U.S. Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 80 U.S. Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 81 U.S. Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 82 U.S. Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 83 U.S. Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 84 U.S. Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 85 U.S. Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 86 U.S. Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 87 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 88 U.S. Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 89 U.S. Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 90 U.S. Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 91 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 92 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 93 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 94 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 95 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 96 Canada Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 97 Canada Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 98 Canada Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 99 Canada Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 100 Canada Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 101 Canada Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 102 Canada Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 103 Canada Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 104 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 105 Canada Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 106 Canada Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 107 Canada Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 108 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 109 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 110 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 111 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 112 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 113 Mexico Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 114 Mexico Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 115 Mexico Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 116 Mexico Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 117 Mexico Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 118 Mexico Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 119 Mexico Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 120 Mexico Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 121 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 122 Mexico Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 123 Mexico Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 124 Mexico Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 125 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 126 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 127 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 128 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 129 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Country, 2018-2031 (Usd Thousand)
Table 130 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 131 Europe Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 132 Europe Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 133 Europe Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 134 Europe Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 135 Europe Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 136 Europe Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 137 Europe Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 138 Europe Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 139 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 140 Europe Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 141 Europe Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 142 Europe Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 143 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 144 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 145 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 146 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 147 Germany Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 148 Germany Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 149 Germany Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)

$4,800
$7,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings